Verus Capital Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$484K Sell
1,049
-60
-5% -$30.4K 0.03% 268
2025
Q4
$628K Buy
1,109
+182
+20% +$96.9K 0.04% 229
2025
Q3
$415K Sell
927
-55
-6% -$26.4K 0.03% 271
2025
Q2
$534K Sell
982
-34
-3% -$17.8K 0.05% 200
2025
Q1
$503K Sell
1,016
-16
-2% -$8.85K 0.05% 202
2024
Q4
$539K Buy
1,032
+38
+4% +$19.8K 0.05% 189
2024
Q3
$488K Buy
994
+123
+14% +$57.3K 0.05% 197
2024
Q2
$387K Buy
871
+90
+12% +$35.8K 0.04% 226
2024
Q1
$312K Sell
781
-70
-8% -$26.5K 0.03% 254
2023
Q4
$287K Sell
851
-6
-0.7% -$1.79K 0.04% 241
2023
Q3
$250K Buy
857
+35
+4% +$10.9K 0.03% 247
2023
Q2
$281K Sell
822
-10
-1% -$3.03K 0.04% 230
2023
Q1
$213K Buy
832
+50
+6% +$12.3K 0.03% 256
2022
Q4
$208K Buy
+782
New +$191K 0.04% 240
2020
Q1
$272K Buy
1,650
+414
+33% +$75.8K 0.09% 146
2019
Q4
$244K Buy
+1,236
New +$231K 0.08% 203

Other funds holding ISRG

Verus Capital Partners's ISRG Position: Q1 2026 in Review

Verus Capital Partners reduced its Intuitive Surgical (ISRG) stake by 5.4% in Q1 2026, selling an estimated $30.4K and leaving 1,049 shares worth $484K. The position accounts for 0.03% of the portfolio, ranked #268.

Verus Capital Partners first reported a position in ISRG in Q4 2019 and has held it in 16 quarters since. The position peaked at $628K in Q4 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Verus Capital Partners held 1,049 shares of Intuitive Surgical worth $484K as of Q1 2026.
  • Verus Capital Partners sold 60 Intuitive Surgical shares in Q1 2026, an estimated $30.4K.
  • Intuitive Surgical made up 0.03% of Verus Capital Partners's portfolio in Q1 2026, its #268 holding.
  • Verus Capital Partners first reported a position in Intuitive Surgical in Q4 2019 and has held it in 16 quarters since.
  • Verus Capital Partners's Intuitive Surgical position peaked at $628K in Q4 2025.
  • 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.